Endothelial Nitric Oxide Synthase Inhibits G<sub>12/13</sub>and Rho-Kinase Activated by the Angiotensin II Type-1 Receptor
Hiroyuki Suzuki(Kao Corporation (Japan)), Satoru Eguchi(University of South Florida), Laura N. Stemmle(Duke Medical Center), Kazuhiro Ishimaru(Kanazawa University), Danny N. Dhanasekaran(Duke Medical Center), Gerald D. Frank(Vanderbilt University), Timothy A. Fields(Duke Medical Center), Eugen Brailoiu(Temple University), Keita Kimura(University Medical Center Groningen), Heigoro Shirai(Temple University), Kunie Eguchi(Vanderbilt University), Akinari Hinoki(Nagoya University), Sadaharu Higuchi(Temple University), Michael V. Autieri(Temple University)
Cited by 39
Related Papers
Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
|Physiological Reviews|2018|1.1k
Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells.
|Journal of Clinical Investigation|1993|573
Calcium-dependent Epidermal Growth Factor Receptor Transactivation Mediates the Angiotensin II-induced Mitogen-activated Protein Kinase Activation in Vascular Smooth Muscle Cells
|Journal of Biological Chemistry|1998|566
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488